Natural IgM antibodies in the immune defence against neoehrlichiosis

References

• Fehr JS, Bloemberg GV, Ritter C, et al. Septicemia caused by tick-borne bacterial pathogen Candidatus Neoehrlichia mikurensis. Emerg Infect Dis. 2010;16:1127–1129.
   PubMed Web of Science ®Google Scholar
• Welinder-Olsson C, Kjellin E, Vaht K, et al. First case of human “Candidatus Neoehrlichia mikurensis” infection in a febrile patient with chronic lymphocytic leukemia. J Clin Microbiol. 2010;48:1956–1959.
   PubMed Web of Science ®Google Scholar
• von Loewenich FD, Geissdorfer W, Disque C, et al. Detection of “Candidatus Neoehrlichia mikurensis” in two patients with severe febrile illnesses: evidence for a European sequence variant. J Clin Microbiol. 2010;48:2630–2635.
   PubMed Web of Science ®Google Scholar
• Grankvist A, Andersson PO, Mattsson M, et al. Infections with the tick-borne bacterium “Candidatus Neoehrlichia mikurensis” mimic noninfectious conditions in patients with B cell malignancies or autoimmune diseases. Clin Infect Dis. 2014;58:1716–1722.
   PubMed Web of Science ®Google Scholar
• Wenneras C. Infections with the tick-borne bacterium Candidatus Neoehrlichia mikurensis. Clin Microbiol Infect. 2015;21:621–630.
   PubMed Web of Science ®Google Scholar
• Andreasson K, Jonsson G, Lindell P, et al. Recurrent fever caused by Candidatus Neoehrlichia mikurensis in a rheumatoid arthritis patient treated with rituximab. Rheumatology (Oxford). 2015;54:369–371.
   PubMed Web of Science ®Google Scholar
• Jones DD, DeIulio GA, Winslow GM. Antigen-driven induction of polyreactive IgM during intracellular bacterial infection. J Immunol. 2012;189:1440–1447.
   PubMed Web of Science ®Google Scholar
• Kawahara M, Rikihisa Y, Isogai E, et al. Ultrastructure and phylogenetic analysis of 'Candidatus Neoehrlichia mikurensis' in the family Anaplasmataceae, isolated from wild rats and found in Ixodes ovatus ticks. Int J Syst Evol Microbiol. 2004;54:1837–1843.
   PubMed Web of Science ®Google Scholar
• Baumgarth N. How specific is too specific? B-cell responses to viral infections reveal the importance of breadth over depth. Immunol Rev. 2013;255:82–94.
   PubMed Web of Science ®Google Scholar
• Baumgarth N. B-1 Cell Heterogeneity and the regulation of natural and antigen-induced IgM production. Front Immunol. 2016;7:324.
   PubMed Web of Science ®Google Scholar
• Ochsenbein AF, Fehr T, Lutz C, et al. Control of early viral and bacterial distribution and disease by natural antibodies. Science. 1999;286:2156–2159.
   PubMed Web of Science ®Google Scholar
• Gronwall C, Vas J, Silverman GJ. Protective roles of natural IgM antibodies. Front Immunol. 2012;3:66.
   PubMed Web of Science ®Google Scholar
• Wang C, Turunen SP, Kummu O, et al. Natural antibodies of newborns recognize oxidative stress-related malondialdehyde acetaldehyde adducts on apoptotic cells and atherosclerotic plaques. Int Immunol. 2013;25:575–587.
   PubMed Web of Science ®Google Scholar
• Baxendale HE, Johnson M, Stephens RC, et al. Natural human antibodies to pneumococcus have distinctive molecular characteristics and protect against pneumococcal disease. Clin Exp Immunol. 2008;151:51–60.
   PubMed Web of Science ®Google Scholar
• Grankvist A, Moore ER, Svensson Stadler L, et al. Multilocus sequence analysis of clinical “candidatus neoehrlichia mikurensis” strains from Europe. J Clin Microbiol. 2015;53:3126–3132.
   PubMed Web of Science ®Google Scholar
• Veneskoski M, Turunen SP, Kummu O, et al. Specific recognition of malondialdehyde and malondialdehyde acetaldehyde adducts on oxidized LDL and apoptotic cells by complement anaphylatoxin C3a. Free Radic Biol Med. 2011;51:834–843.
   PubMed Web of Science ®Google Scholar
• Blumental S, Moisi JC, Roalfe L, et al. Streptococcus pneumoniae serotype 1 burden in the African meningitis belt: exploration of functionality in specific antibodies. Clin Vaccine Immunol. 2015;22:404–412.
   PubMed Web of Science ®Google Scholar
• Abdi H. Partial least squares regression and projection on latent structure regression (PLS regression). WIREs Comp Stat. 2010. doi: 10.1002/wics.051.
   PubMedGoogle Scholar
• Guerra-Silveira F, Abad-Franch F. Sex bias in infectious disease epidemiology: patterns and processes. PLoS One. 2013;8:e62390.
   PubMed Web of Science ®Google Scholar
• Rymkiewicz PD, Heng YX, Vasudev A, et al. The immune system in the aging human. Immunol Res. 2012;53:235–250.
   PubMed Web of Science ®Google Scholar
• Casulo C, Maragulia J, Zelenetz AD. Incidence of hypogammaglobulinemia in patients receiving rituximab and the use of intravenous immunoglobulin for recurrent infections. Clin Lymphoma Myeloma Leuk. 2013;13:106–111.
   PubMed Web of Science ®Google Scholar
• Marco H, Smith RM, Jones RB, et al. The effect of rituximab therapy on immunoglobulin levels in patients with multisystem autoimmune disease. BMC Musculoskelet Disord. 2014;15:178.
   PubMed Web of Science ®Google Scholar
• Bergh AC, Evaldsson C, Pedersen LB, et al. Silenced B-cell receptor response to autoantigen in a poor-prognostic subset of chronic lymphocytic leukemia. Haematologica. 2014;99:1722–1730.
   PubMed Web of Science ®Google Scholar
• Lanemo Myhrinder A, Hellqvist E, Sidorova E, et al. A new perspective: molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies. Blood. 2008;111:3838–3848.
   PubMed Web of Science ®Google Scholar
• Rosen A, Murray F, Evaldsson C, et al. Antigens in chronic lymphocytic leukemia–implications for cell origin and leukemogenesis. Semin Cancer Biol. 2010;20:400–409.
   PubMed Web of Science ®Google Scholar
• Cerutti A, Cols M, Puga I. Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes. Nat Rev Immunol. 2013;13:118–132.
   PubMed Web of Science ®Google Scholar
• Klocperk A, Mejstrikova E, Kayserova J, et al. Low marginal zone-like B lymphocytes and natural antibodies characterize skewed B-lymphocyte subpopulations in del22q11 DiGeorge patients. Clin Immunol. 2015;161:144–149.
   PubMed Web of Science ®Google Scholar
• Kruetzmann S, Rosado MM, Weber H, et al. Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen. J Exp Med. 2003;197:939–945.
   PubMed Web of Science ®Google Scholar
• Mamani-Matsuda M, Cosma A, Weller S, et al. The human spleen is a major reservoir for long-lived vaccinia virus-specific memory B cells. Blood. 2008;111:4653–4659.
   PubMed Web of Science ®Google Scholar
• Wasserstrom H, Bussel J, Lim LC, et al. Memory B cells and pneumococcal antibody after splenectomy. J Immunol. 2008;181:3684–3689.
   PubMed Web of Science ®Google Scholar
• Eisenberg RA, Jawad AF, Boyer J, et al. Rituximab-treated patients have a poor response to influenza vaccination. J Clin Immunol. 2013;33:388–396.
   PubMed Web of Science ®Google Scholar